György M. Keseru
György M. Keseru obtained his Ph.D. degree from Budapest, Hungary, and joined Sanofi-Aventis CHINOIN, heading a chemistry research laboratory. He moved to Gedeon Richter in 1999 as the Head of Computer-Aided Drug Discovery. He earned a D.S. degree from the Hungarian Academy of Science in 2003 and he was invited for a Research Professorship at the Budapest University of Technology and Economics. Since 2003, he has been responsible for lead discovery activity, and more recently he was appointed as the Head of Discovery Chemistry at Gedeon Richter. He contributed to the discovery of the antipsychotic cariprazine that is currently in Phase III clinical trials. His research interests include medicinal chemistry, drug design, and in silico ADME. He has published over 150 papers and more than 10 books and book chapters.
Biography Updated on 31 January 2012